Please login to the form below

Not currently logged in
Email:
Password:

Manifesto puts patients first

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio, the European Association for Bioindustries. In announcing its new policy priorities for 2009-2010, it outlines ways of promoting patient-centred healthcare systems.

The key policy areas involve: communicating the value of biotechnology innovation for healthcare systems; promoting Europe as the leading research hub for biotechnology and life sciences in the world; supporting the EU in delivering on its vision for access to orphan medicinal products for all patients affected by rare diseases; promoting reward for innovation, and sensitivity about, and understanding of, bio-ethical issues and values.

Biotechnology enables the development and manufacture of therapies for a number of rare and very rare diseases including genetic diseases, collectively affecting some 20 to 30 million Europeans and their families. Modern biotechnology leads to more targeted research that allows a better understanding of diseases, their causes and the identification of the best responders to new therapies.  

The chairman of EuropaBio's Healthcare Council, Andrea Rappagliosi, said: "EuropaBio's Healthcare Manifesto is our political road map for how to deliver a patient–centred approach to modern healthcare. This means putting patients first in Europe and working together with health authorities, payers and reimbursement agencies in order to ensure timely access to innovative therapies." 

"Our Healthcare Manifesto clarifies EuropaBio's policy goals and gives our Healthcare Council a strong position when working with policy makers," said Willy De Greef, secretary general of EuropaBio.

21st April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics